US4609542A
Expired / Lapsed
US
⏱️ 0.0 years remaining
New pharmaceutical forms for administration of medicaments by oral route, with programmed release
Assignee: Perrigo Co PLC
•
Filing: 1985-07-01
•
Granted: 1986-09-02
•
Expires: 2005-07-01
Abstract
Abstract The present invention relates to a new pharmaceutical form for oral use in the nature of delayed action and controlled absorption medicaments. This form comprises an association of miniaturized granules obtained by high to very high compression: (a) with pH control agents, (b) coated with excipients determining the slow penetration of digestive and/or (c) coated with a very thin layer of lipids. These miniaturized granules may contain glucose, nay have pH control agents with different solubilities, and may be in the form of miniaturized granules with a pH gradient.
Inventors
- 👤 Donald E. Panoz
- 👤 Gilbert Corneille
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 06:14
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5015; A61J; A61J3/00; A61J3/10; A61K9/14; A61K9/16; A61K9/1605; A61K9/1617; A61K9/5073; A61K9/5084
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
223 words
A new pharmaceutical form of medicament for oral administration with selectively adjustable programmed release and controlled absorption, comprising: (a) granulated highly compressed pulverized particles obtained by high to very high compression at a pressure equal to 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, of an active ingredient comprising potassium phenoxymethylpenicillin with an active excipient containing a physiologically active neutralization agent for controlling the pH, said neutralization agent comprising sodium citrate; (b) granulated highly compressed pulverized particles obtained by high to a very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, containing an active ingredient comprising potassium phenoxymethylpenicillin coated with an excipient determining the slow penetration of the digestive and alimentary liquids, said excipient including polyvinyl-acetate-phthalate; (c) granulated highly compressed pulverized particles containing an active ingredient comprising potassium phenoxymethylpenicillin, obtained by high to very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, coated with a very thin layer of lipids, compressing cholesteryl acetatechloroform in a ratio of 1:2 (weight:volume), said lipids being present at a rate of 5 to 30% in relation to the active ingredients, the proportions by weight of each of particles (a), (b) and (c) being 1:1:1.
Claim 2
Dependent Claim
223 words
A new pharmaceutical form of medicament for oral administration with selectively adjustable programmed release and controlled absorption, comprising: (a) granulated highly compressed pulverized particles obtained by high to very high compression at a pressure equal to 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, of an active ingredient comprising potassium phenoxymethylpenicillin with an active excipient containing a physiologically active neutralization agent for controlling the pH, said neutralization agent comprising sodium citrate; (b) granulated highly compressed pulverized particles obtained by high to a very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, containing an active ingredient comprising potassium phenoxymethylpenicillin coated with an excipient determining the slow penetration of the digestive and alimentary liquids, said excipient including polyvinyl-acetate-phthalate; (c) granulated highly compressed pulverized particles containing an active ingredient comprising potassium phenoxymethylpenicillin, obtained by high to very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, coated with a very thin layer of lipids, compressing cholesteryl acetatechloroform in a ratio of 1:2 (weight:volume), said lipids being present at a rate of 5 to 30% in relation to the active ingredients, the proportions by weight of each of particles (a), (b) and (c) being 1:1:1.
Claim 3
Dependent Claim
225 words
In a pharmaceutical form of medicament for oral administration with selectively adjustable programmed release and controlled absorption, the improvement comprising: (a) granulated highly compressed pulverized particles obtained by high to very high compression at a pressure equal to 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, of an active ingredient comprising potassium phenoxymethylpenicillin with an active excipient containing a physiologically active neutralization agent for controlling the pH, said neutralization agent comprising sodium citrate; (b) granulated highly compressed pulverized particles obtained by high to a very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, containing an active ingredient comprising potassium phenoxymethylpenicillin coated with an excipient determining the slow penetration of the digestive and alimentary liquids, said excipient including polyvinyl-acetate-phthalate; (c) granulated highly compressed pulverized particles containing an active ingredient comprising potassium phenoxymethylpenicillin, obtained by high to very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, coated with a very thin layer of lipids, compressing cholesteryl acetatechloroform in a ratio of 1:2 (weight:volume), said lipids being present at a rate of 5 to 30% in relation to the active ingredients, the proportions by weight of each of particles (a), (b), and (c) being 1:1:1.
Claim 4
Dependent Claim
225 words
In a pharmaceutical form of medicament for oral administration with selectively adjustable programmed release and controlled absorption, the improvement comprising: (a) granulated highly compressed pulverized particles obtained by high to very high compression at a pressure equal to 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, of an active ingredient comprising potassium phenoxymethylpenicillin with an active excipient containing a physiologically active neutralization agent for controlling the pH, said neutralization agent comprising sodium citrate; (b) granulated highly compressed pulverized particles obtained by high to a very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, containing an active ingredient comprising potassium phenoxymethylpenicillin coated with an excipient determining the slow penetration of the digestive and alimentary liquids, said excipient including polyvinyl-acetate-phthalate; (c) granulated highly compressed pulverized particles containing an active ingredient comprising potassium phenoxymethylpenicillin, obtained by high to very high compression at a pressure of 15 tons and thereafter grinding said particles having a diameter between 0.2 and 2 mm, coated with a very thin layer of lipids, compressing cholesteryl acetatechloroform in a ratio of 1:2 (weight:volume), said lipids being present at a rate of 5 to 30% in relation to the active ingredients, the proportions by weight of each of particles (a), (b), and (c) being 1:1:1.
References Cited (Backward Citations)
US2702264A
Cited
US2953497A
Cited
US2996431A
Cited
US3044938A
Cited
GB785262A
Cited
US2809918A
Cited
US2809917A
Cited
US2853420A
Cited
US2897122A
Cited
GB831907A
Cited
US2918411A
Cited
US2991226A
Cited
GB927218A
Cited
US3096248A
Cited
US2993837A
Cited
US3081233A
Cited
US3080294A
Cited
GB934089A
Cited
US3102845A
Cited
US3166476A
Cited
US3115441A
Cited
FR1347413A
Cited
US3325365A
Cited
US3344029A
Cited
GB1204580A
Cited
US3538214A
Cited
FR2051524A1
Cited
US3725470A
Cited
US3629393A
Cited
GB1297476A
Cited
US3728445A
Cited
US4025613A
Cited
US3828106A
Cited
GB1443923A
Cited
US3965256A
Cited
US4016254A
Cited
GB1367608A
Cited
FR2226992A1
Cited
US3954959A
Cited
DE2421273A1
Cited
US4113816A
Cited
US3961004A
Cited
FR2312774A1
Cited
US4016744A
Cited
US4121289A
Cited
FR2353285A1
Cited
US4289795A
Cited
US4341759A
Cited
US4177254A
Cited
US4137300A
Cited
US4267138A
Cited
FR2368272A1
Cited
FR2390959A1
Cited
US4321253A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-09-01 | 1990-03-03 | 1990-09-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-09-01 | 1994-03-03 | 1994-09-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-09-01 | 1998-03-03 | 1998-09-02 | $7700.00 | Window Closed / Lapsed |